Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.94% is 3700% above its 5-year average of 0.13%, near the high end of its 5-year range (-7.49%–4.94%).
157.29% above its 12-month average of 1.92%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.62%.
RETURN ON ASSETS (ROA)
4.94%
RETURN ON ASSETS (ROA) AVG TTM
1.92%
RETURN ON ASSETS (ROA) AVG 3Y
-0.50%
RETURN ON ASSETS (ROA) AVG 5Y
0.13%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+157.29%
CURRENT VS 3Y AVG
+1083.08%
CURRENT VS 5Y AVG
+3700.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+115.32%
vs the sector median at left
Sotera Health Company
Market Cap
$5.23B
Return on Assets (ROA)
4.94%
TTM Avg
1.92%
3Y Avg
-0.50%
5Y Avg
0.13%
Market Cap
$5.24B
Return on Assets (ROA)
-17.02%
TTM Avg
-21.01%
3Y Avg
-19.47%
5Y Avg
-13.88%
Market Cap
$5.25B
Return on Assets (ROA)
15.41%
TTM Avg
17.55%
3Y Avg
14.67%
5Y Avg
15.71%
Market Cap
$5.18B
Return on Assets (ROA)
-5.44%
TTM Avg
-29.17%
3Y Avg
-28.46%
5Y Avg
-27.49%
Market Cap
$5.19B
Return on Assets (ROA)
-45.20%
TTM Avg
-56.55%
3Y Avg
-55.28%
5Y Avg
-47.01%
Market Cap
$5.34B
Return on Assets (ROA)
-1.18%
TTM Avg
1.12%
3Y Avg
-15.90%
5Y Avg
-18.41%
Market Cap
$5.14B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
Market Cap
$5.05B
Return on Assets (ROA)
5.08%
TTM Avg
4.88%
3Y Avg
4.58%
5Y Avg
3.44%
Market Cap
$5.02B
Return on Assets (ROA)
2.30%
TTM Avg
0.76%
3Y Avg
-0.18%
5Y Avg
-0.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sotera Health Company (SHC) | $5.23B | 4.94% | 1.92% | -0.50% | 0.13% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.24B | -17.02% | -21.01% | -19.47% | -13.88% |
| Doximity, Inc. (DOCS)vs › | $5.25B | 15.41% | 17.55% | 14.67% | 15.71% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.18B | -5.44% | -29.17% | -28.46% | -27.49% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | -45.20% | -56.55% | -55.28% | -47.01% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.34B | -1.18% | 1.12% | -15.90% | -18.41% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.14B | -78.04% | -72.67% | -59.05% | -50.29% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.05B | 5.08% | 4.88% | 4.58% | 3.44% |
| Waystar Holding Corp. (WAY)vs › | $5.02B | 2.30% | 0.76% | -0.18% | -0.34% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.46B | -6.97% | -6.55% | -3.96% | -3.96% |
ROA
4.9%
ROE
24.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 2.39% |
| 2024-12-31 | 1.45% |
| 2023-12-31 | 1.64% |
| 2022-12-31 | -7.49% |
| 2021-12-31 | 4.19% |
| 2020-12-31 | -1.40% |
| 2019-12-31 | -0.81% |
| 2018-12-31 | -0.22% |
